Science and Research

Chemotherapy + PD-1/PD-L1 Blockade Should Not Be the Preferred Option in the Neoadjuvant Therapy of NSCLC

  • Hendriks, L. E. L.
  • Remon, J.
  • Reck, M.
Publication details
DOI: 10.1016/j.jtho.2021.11.024
Journal: J Thorac Oncol
Pages: 499-502 
Number: 4
Work Type: Other
Location: ARCN
Disease Area: LC
Partner / Member: Ghd
Access-Number: 35307106

DZL Engagements

chevron-down